Residual benign prostatic glands at the urethrovesical anastomosis after radical retropubic prostatectomy: Prediction and impact on disease outcome

European Urology

Volumn 46, Issue 3, 2004, Pages 321-326

  Paul, Roger ^a   Hoppmann, Mathias ^a   Van Randenborgh, Heiner ^a   Kübler, Hubert ^a   Alschibaja, Michael ^a   Günther, Markus ^a   Hartung, Rudolf ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Benign prostatic glands; Prognosis; Prostate cancer; Radical prostatectomy; Surgical margins

Indexed keywords

ADULT; ANASTOMOSIS; ARTICLE; BIOPSY; CANCER CLASSIFICATION; CONTINENCE; DISSECTION; HUMAN; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; PROSTATE; PROSTATE CANCER; PROSTATECTOMY; RETROSPECTIVE STUDY; RISK ASSESSMENT; SURGICAL TECHNIQUE; URETHRA;

ANASTOMOSIS, SURGICAL; DISEASE PROGRESSION; HUMANS; MALE; MIDDLE AGED; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; URETHRA; URINARY BLADDER;

EID: 4043108374     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eururo.2004.04.023     Document Type: Article

References (12)

1. Augustin H., Hammerer P.G. Disease recurrence after radical prostatectomy. Contemporary diagnostic and therapeutical strategies. Minerva. Urol. Nefrol. 55:2003;251-261
2. Nelson J.B., Lepor H. Prostate cancer: radical prostatectomy. Urol. Clin. North Am. 30:2003;703-723
3. Zhang Y., Glass A., Bennett N., Oyama K.A., Gehan E., Gelmann E.P. Long-term outcomes after radical prostatectomy performed in a community-based health maintenance organization. Cancer. 100:2004;300-307
4. Djavan B, Sesterhann I, Hruby St, Susani M, Haitel A, Etemad, Mostofi FK, McLeod DG, Marberger M. Benign prostatic glands in the surgical margin of radical retropubic Prostatectomies: redefining PSA nadir. J Urol 2000;163A:624.
5. Ravery V. The significance of recurrent PSA after radical prostatectomy: benign versus malignant sources. Semin. Urol. Oncol. 17:1999;127-129
6. Walsh P.C., Lepor H., Eggleston J.C. Radical prostatectomy with preservation of sexual function: anatomical and pathological considerations. Prostate. 4:1983;473-485
7. Pound C.R., Partin A.W., Eisenberger M.A., Chan D.W., Pearson J.D., Walsh P.C. Natural history of progression after PSA elevation following radical prostatectomy. JAMA. 281:1999;1591-1597
8. Ravery V., Hermieu J.F., Hoffmann P., Delmas V., Boccon-Gibod L. Post-treatment PSA, indicator of radical treatment effectiveness of localized cancer of the prostate. Prog. Urol. 6:1996;981-986
9. Blute M.L., Bergstralh E.J., Iocca A., Scherer B., Zincke H. Use of Gleason score, prostate specific antigen, seminal vesicle and margin status to predict biochemical failure after radical prostatectomy. J. Urol. 165:2001;119-215
10. Salomon L., Levrel O., Anastasiadis A.G., Irani J., De La Taille A., Saint F., et al. Prognostic significance of tumor volume after radical prostatectomy: a multivariate analysis of pathological prognostic factors. Eur. Urol. 43:2003;39-44
11. Shah R., Bassily N., Wei J., Mucci N.R., Montie J.E., Sanda M.G., et al. Benign prostatic glands at surgical margins of radical prostatectomy specimens: frequency and associated risk factors. Urology. 56:2000;721-725
12. Wood D.P., Peretsman S.J., Seay T.M. Incidence of benign and malignant prostate tissue in biopsies of the bladder neck after a radical prostatectomy. J. Urol. 154:1995;1443-1446